Mouse Models for Filovirus Infections

被引:55
作者
Bradfute, Steven B. [1 ]
Warfield, Kelly L. [2 ]
Bray, Mike [3 ]
机构
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] Integrated Biotherapeut Inc, Vaccine Dev, Gaithersburg, MD 20878 USA
[3] NIAID, Div Clin Res, NIH, Bethesda, MD 20892 USA
来源
VIRUSES-BASEL | 2012年 / 4卷 / 09期
关键词
filovirus; Ebola; Marburg; mouse models; hemorrhagic fever; EBOLA-VIRUS-INFECTION; PROTECT GUINEA-PIGS; T-CELL RESPONSES; ANTIBODY-DEPENDENT ENHANCEMENT; SMALL-MOLECULE INHIBITOR; HEMORRHAGIC-FEVER; MARBURG VIRUS; NONHUMAN-PRIMATES; POSTEXPOSURE PROTECTION; VACCINE PROTECTS;
D O I
10.3390/v4091477
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The filoviruses marburg- and ebolaviruses can cause severe hemorrhagic fever (HF) in humans and nonhuman primates. Because many cases have occurred in geographical areas lacking a medical research infrastructure, most studies of the pathogenesis of filoviral HF, and all efforts to develop drugs and vaccines, have been carried out in biocontainment laboratories in non-endemic countries, using nonhuman primates (NHPs), guinea pigs and mice as animal models. NHPs appear to closely mirror filoviral HF in humans (based on limited clinical data), but only small numbers may be used in carefully regulated experiments; much research is therefore done in rodents. Because of their availability in large numbers and the existence of a wealth of reagents for biochemical and immunological testing, mice have become the preferred small animal model for filovirus research. Since the first experiments following the initial 1967 marburgvirus outbreak, wild-type or mouse-adapted viruses have been tested in immunocompetent or immunodeficient mice. In this paper, we review how these types of studies have been used to investigate the pathogenesis of filoviral disease, identify immune responses to infection and evaluate antiviral drugs and vaccines. We also discuss the strengths and weaknesses of murine models for filovirus research, and identify important questions for further study.
引用
收藏
页码:1477 / 1508
页数:32
相关论文
共 158 条
  • [1] Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012)
    Adams, M. J.
    Carstens, E. B.
    [J]. ARCHIVES OF VIROLOGY, 2012, 157 (07) : 1411 - 1422
  • [2] Development of a broad-spectrum antiviral with activity against Ebola virus
    Aman, M. Javad
    Kinch, Michael S.
    Warfield, Kelly
    Warren, Travis
    Yunus, Abdul
    Enterlein, Sven
    Stavale, Eric
    Wang, Peifang
    Chang, Shaojing
    Tang, Qingsong
    Porter, Kevin
    Goldblatt, Michael
    Bavari, Sina
    [J]. ANTIVIRAL RESEARCH, 2009, 83 (03) : 245 - 251
  • [3] [Anonymous], VIRUS TAXONOMY
  • [4] Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?
    Baize, S
    Leroy, EM
    Mavoungou, E
    Fisher-Hoch, SP
    [J]. APOPTOSIS, 2000, 5 (01) : 5 - 7
  • [5] Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
    Baize, S
    Leroy, EM
    Georges-Courbot, MC
    Capron, M
    Lansoud-Soukate, J
    Debré, P
    Fisher-Hoch, SP
    McCormick, JB
    McCormick, JB
    Georges, AJ
    [J]. NATURE MEDICINE, 1999, 5 (04) : 423 - 426
  • [6] Inflammatory responses in Ebola virus-infected patients
    Baize, S
    Leroy, EM
    Georges, AJ
    Georges-Courbot, MC
    Capron, M
    Bedjabaga, I
    Lansoud-Soukate, J
    Mavoungou, E
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (01) : 163 - 168
  • [7] Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus
    Barrientos, LG
    O'Keefe, BR
    Bray, M
    Anthony, S
    Gronenborn, AM
    Boyd, MR
    [J]. ANTIVIRAL RESEARCH, 2003, 58 (01) : 47 - 56
  • [8] PATHOLOGY OF EXPERIMENTAL EBOLA VIRUS-INFECTION IN MONKEYS
    BASKERVILLE, A
    BOWEN, ETW
    PLATT, GS
    MCARDELL, LB
    SIMPSON, DIH
    [J]. JOURNAL OF PATHOLOGY, 1978, 125 (03) : 131 - &
  • [9] Lipid raft microdomains: A gateway for compartmentalized trafficking of Ebola and Marburg viruses
    Bavari, S
    Bosio, CM
    Wiegand, E
    Ruthel, G
    Will, AB
    Geisbert, TW
    Hevey, M
    Schmaljohn, C
    Schmaljohn, A
    Aman, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) : 593 - 602
  • [10] Borisevich IV, 1995, VOP VIRUSOL+, V40, P270